Clinical Trial Update: Phase 2a Study to Assess the Efficacy and Safety of AZD4604 in Adult Patients With Moderate-to-Severe Asthma Uncontrolled on Medium-High Dose ICS-LABA [Phase 2]

View source ↗

Summary

A Phase 2a trial assessing the efficacy and safety of AZD4604 in adults with moderate-to-severe asthma uncontrolled on medium-high dose ICS-LABA has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• AZD4604

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED